At the forefront of T Cell Therapy for Cancer
Cellular Therapeutics deliver high quality cell therapy products to patients.
Our strategy is to develop the technology of cell therapy manufacturing so it can be applied on a routine basis to large numbers of patients. Our focus is on the development of Tumour Infiltrating Lymphocytes (TIL) for cancer.
Who are we…..
We have built upon the expertise of researchers who have successfully undertaken scientific and clinical research at the University of Manchester within the Research Group of Professor Robert Hawkins. The group is a leader in the field of Cellular Therapy of Cancer having successfully provided cell products for several complex clinical trials involving: cell selection, gene therapy, expansion of patient derived cells.
Cell Therapy product development…..
Tumour Infiltrating Lymphocytes (TIL) as a cell therapy to treat metastatic melanoma show huge potential. CTL is developing cell therapies based on TIL technology for a variety of cancer indications.
Using clean room free technology developed specifically for the processes of cell therapy, Cellular Therapeutics has the capability to produce individualised cell therapy products in a cost effective and high throughput manner.